alti20140916_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): September 12, 2014

 

Altair Nanotechnologies Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

1-12497

 

33-1084375

(State or other jurisdiction of

 

(Commission

 

(IRS Employer

incorporation or organization)   File Number)   Identification No.)

 

         
204 Edison Way        
Reno, NV         89502 
   (Address of Principal Executive Offices)               (Zip Code)

 

 

Registrant's Telephone Number, Including Area Code:

(775) 856-2500

 

 

          N/A          

(Former name, former address, and formal fiscal year, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

 

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

 

 
 
 

 

Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

 

Election of Director

 

On September 12, 2014, the Board of Directors of Altair Nanotechnologies Inc. (the “Company”), appointed James Tao Zhan as a director of the Company. Mr. Zhan is entitled to a salary of $300,000 per year as the Chief Executive Officer of the Company and will not be separately compensated as a director.

 

 

 
 
 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Altair Nanotechnologies Inc.

 

 

 

 

 

 

 

 

 

Dated: September 16, 2014                   

By:

/s/ Karen Werner

 

 

Karen Werner, Interim Chief Financial Officer